Clinical trial
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study.
NCT04378023 is registered in ClinicalTrials.gov with Hospital Vall d'Hebron as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study.
- Lead sponsor
- Hospital Vall d'Hebron
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 24, 2020
- Completion date
- June 1, 2027
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
unresectable cholangiocarcinoma